Background: Respiratory syncytial virus (RSV) poses a significant respiratory health risk to senior citizens, contributing substantially to hospitalizations and mortality. With the recent approval of three RSV vaccines for the elderly, it is critical to understand the factors that can shape the RSV vaccination attitudes to inform public health strategies that can enhance uptake among this vulnerable population.

Objectives: This study aimed to investigate the potential factors that could influence the attitudes toward RSV vaccination among senior citizens in Arab countries.

Design: A multinational cross-sectional study, adhering to STROBE guidelines, was conducted using a survey instrument previously validated through exploratory factor analysis to assess attitudes toward the newly approved RSV vaccine.

Methods: A self-administered online survey was distributed conveniently among senior citizens mainly across five Arab countries. The survey collected data on demographics, vaccination history, and key constructs related to RSV vaccine attitude, including "Fear," "Information," "Accessibility," "Benefits," and "Conspiracy."

Results: A total of 483 participants were included in the study, with the majority from five Arab countries: Jordan ( = 239, 49.5%), Kuwait ( = 74, 15.3%), Egypt ( = 68, 14.1%), Saudi Arabia ( = 51, 10.6%), and the UAE ( = 23, 4.8%), alongside participants from other Arab nations ( = 28, 5.8%). Among the respondents, 51.1% ( = 247) expressed acceptance of the RSV vaccine, 22.4% ( = 108) were hesitant, and 26.5% ( = 128) exhibited refusal. Multivariate analysis identified perceived benefits (β = 0.484,  < 0.001), information needs (β = 0.229,  < 0.001), and previous vaccination history (β = 0.087,  = 0.016) as significant positive predictors of vaccine acceptance. Conversely, stronger conspiracy beliefs (β = -0.083,  = 0.035) were associated with vaccine resistance. Fear and accessibility were not significant predictors of vaccine attitudes.

Conclusion: The findings showed that perceived benefits, access to reliable information, previous vaccination history, and conspiracy beliefs are essential to promote RSV vaccine acceptance among Arab seniors. These factors are recommended to improve RSV vaccine uptake in this vulnerable population.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869265PMC
http://dx.doi.org/10.1177/25151355251324384DOI Listing

Publication Analysis

Top Keywords

rsv vaccine
12
senior citizens
12
perceived benefits
8
vaccination history
8
rsv
8
rsv vaccination
8
citizens arab
8
arab countries
8
arab
5
vaccination
4

Similar Publications

Background: Respiratory syncytial virus (RSV) is a major cause of severe respiratory infections in infants, especially under 5 years of age. Several studies have reported that interactions between RSV and bacteria like Streptococcus pneumoniae (SP), Moraxella catarrhalis (MC), Haemophilus influenzae (HI) and Staphylococcus aureus (SA) may influence their pathogenicity and the clinical outcome of infection. However, existing knowledge about RSV-bacterial interactions in infants comes primarily from cross-sectional studies, which cannot evaluate the influence of infection sequence on these interactions.

View Article and Find Full Text PDF

Harnessing Computational Strategies to Overcome Challenges in mRNA Vaccines.

Physiology (Bethesda)

March 2025

Department of Critical Care Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.

In recent years, the introduction of mRNA vaccines for SARS-CoV2 and RSV has highlighted the success of the mRNA technology platform. Designing mRNA sequences involves multiple components and requires balancing several parameters, including enhancing transcriptional efficiency, boosting antigenicity, and minimizing immunogenicity. Moreover, changes in the composition and properties of delivery vehicles can also affect vaccine performance.

View Article and Find Full Text PDF

Background: More data is required to contextualise respiratory-syncytial-virus (RSV) disease burden, versus other vaccine-preventable respiratory-viral-infections (RVIs) in older adults. We aimed to compare severity of RSV in hospitalized adults versus influenza/boosted COVID-19.

Methods: Retrospective population-based cohort study, including all adult RSV hospitalizations (2021-2023) in Singapore.

View Article and Find Full Text PDF

Chronic respiratory diseases, including asthma, chronic obstructive pulmonary disease, and bronchiectasis, are significant global health concerns associated with recurrent exacerbations, hospitalization, and increased mortality. Preventive strategies, particularly vaccination, play a crucial role in managing these diseases by reducing infection-related exacerbations and stabilizing lung function. This review summarizes the recommendations provided by four major Italian scientific societies on vaccination against key respiratory pathogens, including respiratory syncytial virus, influenza, SARS-CoV-2, Streptococcus pneumoniae, and varicella-zoster virus (VZR), which pose serious risks to individuals with chronic respiratory conditions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!